Published in PLoS One on November 25, 2014
Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget (2015) 1.19
TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res (2015) 1.14
Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Oncotarget (2016) 0.89
The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature. J Cancer (2016) 0.88
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Oncotarget (2015) 0.88
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis (2016) 0.86
MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer. Tumour Biol (2015) 0.85
Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells. J Cancer (2016) 0.83
Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci (2016) 0.80
Long noncoding RNAs in head and neck cancer. Oncotarget (2016) 0.80
High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma. J Cancer (2017) 0.79
Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer. Mol Cancer (2017) 0.79
Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma. Oncotarget (2017) 0.76
LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells. Braz J Med Biol Res (2017) 0.75
RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma. Cell Death Dis (2016) 0.75
Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. J Cancer (2017) 0.75
The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review. Oncotarget (2017) 0.75
Role of tumor microenvironment in tumorigenesis. J Cancer (2017) 0.75
The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism. Onco Targets Ther (2017) 0.75
Role of long non-coding RNAs in glucose metabolism in cancer. Mol Cancer (2017) 0.75
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Evolution and functions of long noncoding RNAs. Cell (2009) 17.54
Long noncoding RNAs with enhancer-like function in human cells. Cell (2010) 13.00
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell (2010) 12.27
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell (2011) 10.50
A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell (2011) 9.24
Long noncoding RNAs: functional surprises from the RNA world. Genes Dev (2009) 9.14
The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science (2008) 8.45
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature (2004) 6.83
The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet (2011) 5.62
The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol (2012) 5.60
Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol (2011) 3.88
A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev (2008) 3.85
Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene (2012) 3.83
Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res (2011) 3.38
p53 dynamics control cell fate. Science (2012) 3.30
Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology (2011) 3.05
Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res (2011) 2.64
LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res (2013) 2.38
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling. Cell (2014) 2.12
An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood (2008) 1.93
DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer. Eur Urol (2004) 1.89
Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci (2013) 1.88
Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene (2010) 1.78
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res (2012) 1.66
A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res (2004) 1.65
Wild-type p53: tumors can't stand it. Cell (2007) 1.64
Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol (2006) 1.44
P53 is a tumor suppressor gene. Cell (2004) 1.33
Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol (2008) 1.28
Current and emerging treatment options for nasopharyngeal carcinoma. Onco Targets Ther (2012) 1.10
Current treatment of nasopharyngeal carcinoma. Eur J Cancer (2011) 1.10
Advances in nasopharyngeal carcinoma. Curr Opin Oncol (2008) 1.06
Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol (2013) 1.05
LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene (2013) 1.04
MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma. Biochim Biophys Acta (2011) 1.04
Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med (2006) 1.03
Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol (2006) 0.99
Current treatment options for local residual nasopharyngeal carcinoma. Curr Treat Options Oncol (2013) 0.99
Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci (2011) 0.95
Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci (2014) 0.95
Long non-coding RNAs in cancer. Sci China Life Sci (2012) 0.92
Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma. Biomed Res Int (2014) 0.86
LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One (2013) 0.86
Tumor suppression by p53: fall of the triumvirate? Cell (2012) 0.84
Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response. J Cancer Res Clin Oncol (2011) 0.83